Prosecution Insights
Last updated: August 17, 2026

Examiner: BOWERS, ERIN M

Tech Center 1600 • Art Units: 1653 1675

This examiner grants 55% of resolved cases

Performance Statistics

55.1%
Allow Rate
-4.9% vs TC avg
605
Total Applications
+10.5%
Interview Lift
1289
Avg Prosecution Days
Based on 546 resolved cases, 2023–2026

Rejection Statute Breakdown

6.5%
§101 Eligibility
9.9%
§102 Novelty
46.1%
§103 Obviousness
26.4%
§112 Clarity

Currently Pending Office Actions

App #TitleStatusAssignee
16821807 NOVEL EUKARYOTIC CELL-FREE PROTEIN EXPRESSION SYSTEM THAT DOES NOT REQUIRE AN ARTIFICIAL ENERGY REGENERATION SYSTEM Final Rejection Fraunhofer-Gesellschaft zur Förderung der angewandten Forschung e.V.
18701567 DELIVERY OF THERAPEUTIC RECOMBINANT URICASE USING NANOPARTICLES Non-Final OA Georgia Tech Research Corporation
18568883 METHOD AND APPARATUS FOR RAPIDLY TESTING MICROORGANISM Non-Final OA HITACHI HIGH-TECH CORPORATION
18223989 COMPOSITIONS INCLUDING ENDOPHYTES FOR IMPROVING PLANT NUTRITION, GROWTH,AND PERFORMANCE AND METHODS OF USING THE SAME Non-Final OA University of Washington
18599563 Deep Eutectic Solvent Stabilized Enzyme-Based Electrochemical Assay Probes for Use in the Field Non-Final OA The Government of the United States of America, as represented by the Secretary of the Navy
18658276 EXTRAMAMMARY PAGET DISEASE BIOMARKERS AND USES THEREOF Non-Final OA THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION

Facing This Examiner?

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.

Build Your Strategy

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month